Eplerenone: A candidate drug to mitigate long-term maternal vascular dysfunction following preeclampsia.

MLA

de Alwis, Natasha, et al. “Eplerenone: A Candidate Drug to Mitigate Long-Term Maternal Vascular Dysfunction Following Preeclampsia.” Pregnancy Hypertension, vol. 36, Aug. 2024, p. 26. EBSCOhost, https://doi.org/10.1016/j.preghy.2024.01.054.

APA

de Alwis, N., Binder, N. K., Fato, B. R., Beard, S., Kaitu’u Lino, T. J., & Hannan, N. J. (2024). Eplerenone: A candidate drug to mitigate long-term maternal vascular dysfunction following preeclampsia. Pregnancy Hypertension, 36, 26. https://doi.org/10.1016/j.preghy.2024.01.054

Chicago

de Alwis, Natasha, Natalie K Binder, Bianca R Fato, Sally Beard, Tu’uhevaha J Kaitu’u Lino, and Natalie J Hannan. 2024. “Eplerenone: A Candidate Drug to Mitigate Long-Term Maternal Vascular Dysfunction Following Preeclampsia.” Pregnancy Hypertension 36 (August): 26. doi:10.1016/j.preghy.2024.01.054.